{"disease":{"id":"leigh-syndrome","name":"leigh syndrome"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03137355","title":"The International Registry for Leigh Syndrome","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"The University of Texas Health Science Center, Houston","has_results":false},{"nct_id":"NCT06967831","title":"Drug Repurposing for Mitochondrial Disorders Using iPSCs Derived Neural Cells","phase":"","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04378075","title":"A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":68,"lead_sponsor_name":"PTC Therapeutics","has_results":true},{"nct_id":"NCT01721733","title":"Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT02352896","title":"Long-Term Safety and Efficacy Evaluation of EPI-743 in Children With Leigh Syndrome","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"PTC Therapeutics","has_results":false},{"nct_id":"NCT05277363","title":"A Study of the Natural Course of SURF1 Deficiency","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Taysha Gene Therapies, Inc.","has_results":false},{"nct_id":"NCT03747328","title":"ABI-009 (Nab-sirolimus) in Patients With Genetically-confirmed Leigh or Leigh-like Syndrome","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Aadi Bioscience, Inc.","has_results":false}],"total":7},"guidelines":[],"source":"Drug Landscape verified database"}